EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 84 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $2,428,000 | -31.4% | 284,988 | -28.8% | 0.08% | +3.8% |
| Q1 2021 | $3,540,000 | -28.0% | 400,000 | 0.0% | 0.08% | -32.5% |
| Q4 2020 | $4,916,000 | +34.4% | 400,000 | -11.0% | 0.12% | -17.0% |
| Q3 2020 | $3,659,000 | -45.6% | 449,510 | -35.8% | 0.14% | -44.9% |
| Q2 2020 | $6,720,000 | +21.2% | 700,000 | -14.1% | 0.26% | -0.8% |
| Q1 2020 | $5,543,000 | -55.4% | 815,127 | -2.2% | 0.26% | -48.0% |
| Q4 2019 | $12,418,000 | +21.4% | 833,400 | -16.5% | 0.50% | -20.4% |
| Q3 2019 | $10,228,000 | -16.1% | 997,892 | -13.2% | 0.62% | -11.0% |
| Q2 2019 | $12,190,000 | – | 1,150,000 | – | 0.70% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 694,232 | $8,532,000 | 5.82% |
| P.A.W. CAPITAL CORP | 400,000 | $4,916,000 | 4.34% |
| Telemetry Investments, L.L.C. | 128,848 | $1,584,000 | 2.68% |
| Trellus Management Company, LLC | 206,404 | $2,537,000 | 2.09% |
| KNOTT DAVID M | 295,035 | $3,626,000 | 1.64% |
| 683 Capital Management, LLC | 2,683,600 | $32,982,000 | 1.56% |
| INTERWEST VENTURE MANAGEMENT CO | 764,918 | $9,401,000 | 1.17% |
| TOWERVIEW LLC | 130,000 | $1,598,000 | 1.14% |
| Vivo Capital, LLC | 1,791,257 | $22,015,000 | 0.98% |
| Altium Capital Management LP | 197,500 | $2,427,000 | 0.91% |